1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. OPUS GENETICS INC.
Opus Genetics Inc.
XNAS: IRD
3.71 -0.37 (-9.07%)
948.9K
XNAS Volume

XNAS 24 Jun, 2026 5:30 PM (EDT)

Watchlist

Portfolio

Alert

Opus Genetics Inc - IRD - stock price prediction, stock price target, analyst ratings from 17 analysts

Opus Genetics Inc has a share price target of US$ 10, revenue growth forecast of 7.7%, and profit growth estimate of -90.5% for FY26, based on top 17 analyst calls.